Exploring Preclinical & Translational Strategies to Advance Autoimmune Cell Therapy Toward Clinical Readiness

3:30 pm - Wednesday 2nd December 2026

  • Highlighting how emerging preclinical datasets and early PK insights can be leveraged to inform translational decision-making ahead of clinical readouts
  • Addressing key challenges in bridging preclinical findings to human biology to improve confidence in safety and mechanism before entering later-stage trials
  • Integrating translational learnings to guide clinical trial design strategy while managing expectations around early-stage data maturity

Speakers:

Chief Science & Technical Officer
Quell Therapeutics